Related Experiment Videos
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma
Anders Lorentzen1, Lotte K Vogel, Rikke H Lewinsky
1Eucaryotic Cell Biology Research Group, Department of Science, Roskilde University, Roskilde, Denmark. anbl@ruc.dk
Background:
It has recently been shown that NDRG2 mRNA is down-regulated or undetectable in several human cancers and cancer cell-lines. Although the function of NDRG2 is unknown, high NDRG2 expression correlates with improved prognosis in high-grade gliomas. The aim of this study has been to examine NDRG2 mRNA expression in colon cancer. By examining affected and normal tissue from individuals with colorectal adenomas and carcinomas, as well as in healthy individuals, we aim to determine whether and at which stages NDRG2 down-regulation occurs during colonic carcinogenesis.
Methods:
Using quantitative RT-PCR, we have determined the mRNA levels for NDRG2 in low-risk (n = 15) and high-risk adenomas (n = 57), colorectal carcinomas (n = 50) and corresponding normal tissue, as well as control tissue from healthy individuals (n = 15). NDRG2 levels were normalised to beta-actin.
Results:
NDRG2 mRNA levels were lower in colorectal carcinomas compared to normal tissue from the control group (p < 0.001). When comparing adenomas/carcinomas with adjacent normal tissue from the same individual, NDRG2 expression levels were significantly reduced in both high-risk adenoma (p < 0.001) and in colorectal carcinoma (p < 0.001). There was a trend for NDRG2 levels to decrease with increasing Dukes' stage (p < 0.05).
Conclusion:
Our results demonstrate that expression of NDRG2 is down-regulated at a late stage during colorectal carcinogenesis. Future studies are needed to address whether NDRG2 down-regulation is a cause or consequence of the progression of colorectal adenomas to carcinoma.
Insights
NDRG2 mRNA is down-regulated in late-stage colorectal cancer. This study investigated NDRG2 expression in colon cancer, finding reduced levels in carcinomas and high-risk adenomas, suggesting a role in carcinogenesis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- NDRG2 mRNA is undetectable or down-regulated in various human cancers.
- High NDRG2 expression correlates with better prognosis in high-grade gliomas.
- The precise function of NDRG2 remains largely unknown.
Purpose of the Study:
- To investigate NDRG2 mRNA expression in colon cancer.
- To determine the stage at which NDRG2 down-regulation occurs during colonic carcinogenesis.
- To analyze NDRG2 expression in colorectal adenomas and carcinomas.
Main Methods:
- Quantitative RT-PCR was used to measure NDRG2 mRNA levels.
- NDRG2 levels were assessed in low-risk adenomas, high-risk adenomas, and colorectal carcinomas.
- Expression levels were normalized to beta-actin and compared between cancerous and normal tissues.
Main Results:
- NDRG2 mRNA levels were significantly lower in colorectal carcinomas compared to normal control tissue.
- NDRG2 expression was significantly reduced in both high-risk adenomas and colorectal carcinomas versus adjacent normal tissue.
- A trend indicated decreasing NDRG2 levels with increasing Dukes' stage.
Conclusions:
- NDRG2 expression is down-regulated during the late stages of colorectal carcinogenesis.
- Further research is required to ascertain if NDRG2 down-regulation causes or results from tumor progression.
- NDRG2 may serve as a potential biomarker in colorectal cancer.
Related Concept Videos
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Abnormal Proliferation